A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel
- Status
- COMPLETED
- Phase
- NA
Use of Low-frequency Magnetic Fields in the Hybrid Treatment of COVID-19 Patients
- Status
- UNKNOWN
- Phase
- NA
Frontline Clinician Psilocybin Study
- Status
- COMPLETED
- Phase
- PHASE3
Breath Samples Collection Clinical Trial, for Development of the TERA BioStation T101, Intended for CoV-19 Exhalation Products Detection.
- Status
- UNKNOWN
- Phase
- NA
A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Effect of Covid 19 Infection on Fetomaternal Outcome
- Status
- UNKNOWN
- Phase
- N/A
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Post Covid-19 Vaccination Development or Flare of ARD
- Status
- UNKNOWN
- Phase
- N/A
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
- Status
- COMPLETED
- Phase
- N/A
Lung Ultrasound in Comparison With C.T in Covid-19
- Status
- UNKNOWN
- Phase
- N/A
Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail
- Status
- WITHDRAWN
- Phase
- PHASE1
Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness
- Status
- WITHDRAWN
- Phase
- PHASE3
Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness
- Status
- WITHDRAWN
- Phase
- PHASE3
Impact of the Genetic Polymorphism on COVID-19 in Egypt
- Status
- UNKNOWN
- Phase
- N/A
Measurment of Interleuukin-6 at Exhaled Breath Condensate of Covid-19 Patients and Post Covid-19 Patients With Lung Fibrosis Randomized Controlled Study
- Status
- UNKNOWN
- Phase
- N/A
Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.
- Status
- UNKNOWN
- Phase
- PHASE4
Convalescent Plasma in Hospitalized COVID-19 Patients
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2